Literature DB >> 21577318

Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.

Britta Kleist1, Li Xu, Guojun Li, Christian Kersten.   

Abstract

The recently advanced cancer stem cell model postulates that progression and metastasis of cancer are mainly driven by tumor cells with stem cell properties. Intestinal cancer stem cells are difficult to study due to the lack of reliable markers, but expression of the Wnt target gene Lgr5 is promising to define at least stem cell like cells in intestinal and colorectal cancer. The aim of this study was to find a possible link of stem cell like cancer cells to the metastatic process of colorectal cancer. To this end, we evaluated immunohistochemical Lgr5 expression in 31 distant metastases and in primary tumor compartments with relevance for metastasizing, comprising 89 colorectal carcinomas. Lgr5 expression was seen in 51.6% of distant metastases. 12.9%, 14.8% and 26.7% of primary tumors with histologically confirmed tumor buds, angioinvasion and perineural infiltrates, respectively, showed evidence of Lgr5 expression in these tumor compartments. However, distant metastases, which were derived from carcinomas with such Lgr5 positive tumor compartments, showed 6- to 11.5-fold higher median value of Lgr5 expression compared to those metastases derived from tumors without Lgr5 expressing cells in these compartments. These differences between the metastases were statistically significant, if being related to tumor buds (all tumors; p = 0.047) and to vascular infiltrates (stage IV tumors; p = 0.007). In conclusion, our results point to rare evidence of Lgr5 positive stem cell like cells in the metastatic cascade of colorectal cancer, but these few cells might be biologically powerful in the metastatic process of cancer subsets. Clonal analysis is necessary to proof this hypothesis.

Entities:  

Keywords:  Lgr5; metastasis; stem cell like cells; tumor compartments

Mesh:

Substances:

Year:  2011        PMID: 21577318      PMCID: PMC3093057     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  25 in total

Review 1.  Gastrointestinal stem cells in development and cancer.

Authors:  S Brabletz; O Schmalhofer; T Brabletz
Journal:  J Pathol       Date:  2009-01       Impact factor: 7.996

2.  Significance of Lgr5(+ve) cancer stem cells in the colon and rectum.

Authors:  Hidekazu Takahashi; Hideshi Ishii; Naohiro Nishida; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Takehiko Yokobori; Koshi Mimori; Hirofumi Yamamoto; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2010-12-02       Impact factor: 5.344

Review 3.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

Authors:  Riccardo Fodde; Thomas Brabletz
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

4.  Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

Authors:  L Vermeulen; M Todaro; F de Sousa Mello; M R Sprick; K Kemper; M Perez Alea; D J Richel; G Stassi; J P Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

5.  Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.

Authors:  Inti Zlobec; Kristi Baker; Parham Minoo; Jeremy R Jass; Luigi Terracciano; Alessandro Lugli
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

6.  Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue.

Authors:  Laren Becker; Qin Huang; Hiroshi Mashimo
Journal:  ScientificWorldJournal       Date:  2008-11-23

Review 7.  The cancer stem cell hypothesis: in search of definitions, markers, and relevance.

Authors:  Michail Shipitsin; Kornelia Polyak
Journal:  Lab Invest       Date:  2008-03-31       Impact factor: 5.662

8.  Identification of stem cells in small intestine and colon by marker gene Lgr5.

Authors:  Nick Barker; Johan H van Es; Jeroen Kuipers; Pekka Kujala; Maaike van den Born; Miranda Cozijnsen; Andrea Haegebarth; Jeroen Korving; Harry Begthel; Peter J Peters; Hans Clevers
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

9.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.

Authors:  Sergey V Shmelkov; Jason M Butler; Andrea T Hooper; Adilia Hormigo; Jared Kushner; Till Milde; Ryan St Clair; Muhamed Baljevic; Ian White; David K Jin; Amy Chadburn; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; Gavin Thurston; George D Yancopoulos; Michael D'Angelica; Nancy Kemeny; David Lyden; Shahin Rafii
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

10.  CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer.

Authors:  S Maeda; H Shinchi; H Kurahara; Y Mataki; K Maemura; M Sato; S Natsugoe; T Aikou; S Takao
Journal:  Br J Cancer       Date:  2008-03-18       Impact factor: 7.640

View more
  21 in total

1.  Lgr5 is a potential prognostic marker in patients with cervical carcinoma.

Authors:  Bo Sun; Xiufeng Ye; Yuan Li; Weiyuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Single nucleotide polymorphisms of the adult intestinal stem cell marker Lgr5 in primary and metastatic colorectal cancer.

Authors:  Britta Kleist; Li Xu; Christian Kersten; Violetta Seel; Guojun Li; Micaela Poetsch
Journal:  Am J Transl Res       Date:  2012-07-20       Impact factor: 4.060

3.  IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease.

Authors:  Andrea S Henden; Motoko Koyama; Renee J Robb; Adriana Forero; Rachel D Kuns; Karshing Chang; Kathleen S Ensbey; Antiopi Varelias; Stephen H Kazakoff; Nicole Waddell; Andrew D Clouston; Rabina Giri; Jakob Begun; Bruce R Blazar; Mariapia A Degli-Esposti; Sergei V Kotenko; Steven W Lane; Kate L Bowerman; Ram Savan; Philip Hugenholtz; Kate H Gartlan; Geoffrey R Hill
Journal:  Blood       Date:  2021-08-26       Impact factor: 25.476

4.  Lgr5 over-expression is positively related to the tumor progression and HER2 expression in stage pTNM IV colorectal cancer.

Authors:  Feng-Juan Gao; Jie-Yu Chen; Hong-Yan Wu; Jiong Shi; Ming Chen; Xiang-Shan Fan; Qin Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

Review 5.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.

Authors:  Anthony P Davenport; Stephen P H Alexander; Joanna L Sharman; Adam J Pawson; Helen E Benson; Amy E Monaghan; Wen Chiy Liew; Chidochangu P Mpamhanga; Tom I Bonner; Richard R Neubig; Jean Philippe Pin; Michael Spedding; Anthony J Harmar
Journal:  Pharmacol Rev       Date:  2013-05-17       Impact factor: 25.468

6.  Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.

Authors:  Zhi-Xue Zheng; Yu Sun; Zhao-De Bu; Lian-Hai Zhang; Zi-Yu Li; Ai-Wen Wu; Xiao-Jiang Wu; Xiao-Hong Wang; Xiao-Jing Cheng; Xiao-Fang Xing; Hong Du; Jia-Fu Ji
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

7.  Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer.

Authors:  Hung-Chih Hsu; Yi-Shiuan Liu; Kai-Chi Tseng; Cheng-Lung Hsu; Ying Liang; Tsai-Sheng Yang; Jinn-Shiun Chen; Rei-Ping Tang; Shu-Jen Chen; Hua-Chien Chen
Journal:  Int J Colorectal Dis       Date:  2013-06-20       Impact factor: 2.571

8.  DCLK1 immunoreactivity in colorectal neoplasia.

Authors:  Giuseppe Gagliardi; Monica Goswami; Roberto Passera; Charles F Bellows
Journal:  Clin Exp Gastroenterol       Date:  2012-04-11

9.  Identification, isolation and characterization of human LGR5-positive colon adenoma cells.

Authors:  Michael K Dame; Durga Attili; Shannon D McClintock; Priya H Dedhia; Peter Ouillette; Olaf Hardt; Alana M Chin; Xiang Xue; Julie Laliberte; Erica L Katz; Gina M Newsome; David R Hill; Alyssa J Miller; Yu-Hwai Tsai; David Agorku; Christopher H Altheim; Andreas Bosio; Becky Simon; Linda C Samuelson; Jay A Stoerker; Henry D Appelman; James Varani; Max S Wicha; Dean E Brenner; Yatrik M Shah; Jason R Spence; Justin A Colacino
Journal:  Development       Date:  2018-03-14       Impact factor: 6.862

10.  Expression of LGR-5, MSI-1 and DCAMKL-1, putative stem cell markers, in the early phases of 1,2-dimethylhydrazine-induced rat colon carcinogenesis: correlation with nuclear β-catenin.

Authors:  Angelo Pietro Femia; Piero Dolara; Maddalena Salvadori; Giovanna Caderni
Journal:  BMC Cancer       Date:  2013-02-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.